Dan is the founder of generic drugmaker Novopharm, he sold it in 2000 for an estimated $430 million. "Canadian Business" magazine ranked him as the 58th richest Canadian in 2010.
Dan is the founder of generic drugmaker Novopharm, he sold it in 2000 for an estimated $430 million. "Canadian Business" magazine ranked him as the 58th richest Canadian in 2010.